Thionamide-induced agranulocytosis (TIA), namely antithyroid drug (ATD)-induced agranulocytosis, is one of the most feared adverse effect of ATDs. It is defined as a granulocyte count of less than 0.5 × 109/L after ATD administration. Several studies reported that TIA is associated with human leukocyte antigen (HLA) and nearby genes. Our previous study found that the susceptibility genes of TIA are similar in north China and European populations.
We evaluated the associations of 23 candidate single nucleotide polymorphisms (SNPs) in 37 patients with TIA and 254 patients with Graves’ disease (GD) as controls by iPLEX MassARRAY system.
Five SNPs in the MHC class I polypeptide-related sequence A(MICA) genes [rs4349859 (p = 1.43E-7); rs145575084 (p = 5.79E-6); rs116135464 (p = 3.70E-5); rs148015908 (p = 3.79E-5) and rs189600525 (p = 2.15E-4)] were found to be significantly associated with TIA after Bonferroni correction. After combining with previous data of rs4349859 and HLA-B*27:05, the haplotype analysis showed that patients carrying P-A-C-A-T-T-A haplotype have a higher risk of TIA (p = 9.76E-7; OR = 14.85, 95% CI 3.63–60.77).
Our findings suggest that five high linked SNPs of MICA gene are significantly associated with susceptibility to TIA.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, and tables.
Weetman AP (2000) Graves' Disease. N Engl J Med 343:1236–1248. https://doi.org/10.1056/NEJM200010263431707
Ross DS et al (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343–1421
Cooper DS (2005) Antithyroid drugs. N Engl J Med 352:905–917
Watanabe N et al (2012) Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab 97:E49–E53
Cheung CL et al (2016) HLA-B* 38: 02: 01 predicts carbimazole/methimazole-induced agranulocytosis. Clin Pharmacol Ther 99:555–561
Nakamura H, Miyauchi A, Miyawaki N, Imagawa J (2013) Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metabol 98:4776–4783
Kobayashi S et al (2014) Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. Thyroid 24:796–801
Kim HK et al (2015) Characteristics of Korean patients with antithyroid drug-induced agranulocytosis: a multicenter study in Korea. Endocrinol Metabol 30:475–480
Csernok E, Ernst M, Schmitt W, Bainton D, Gross W (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244–250
Owen CA, Campbell MA, Boukedes SS, Campbell EJ (1995) Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J Immunol 155:5803–5810
Vita R, Mazzi V, Antonelli A, Benvenga S (2013) Antithyroid medications and psychosis. Expert Opin Drug Saf 12:865–872
Chen P-L et al (2015) Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun 6:7633
Thao MP, Tuan PVA, Linh LGH et al (2018) Association of HLA-B∗38:02 with Antithyroid Drug-Induced Agranulocytosis in Kinh Vietnamese Patients. Int J Endocrinol. 2018:7965346
He Y et al (2017) Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China. Sci Rep 7:11950
Hallberg P et al (2016) Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol 4:507–516
Zou Y, Stastny P (2010) Role of MICA in the immune response to transplants. Tissue Antigens 76:171–176
Tian W et al (2006) MICA-STR, HLA-B haplotypic diversity and linkage disequilibrium in the Hunan Han population of southern China. Int J Immunogen 33:241–245
Yang J et al (2013) The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr J 60(2):185–189. https://doi.org/10.1507/endocrj.ej12-0332
Ostrovsky O et al (2003) NQO2 gene is associated with clozapine induced agranulocytosis. Hum Immunol 10:S140
Turbay D et al (1997) Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood 89:4167–4174
Barrett JC, Fry B, Maller J, Daly MJ (2004) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Askar M et al (2017) MHC class I chain-related gene A (MICA) donor-recipient mismatches and MICA-129 polymorphism in unrelated donor hematopoietic cell transplantations has no impact on outcomes in acute lymphoblastic leukemia, acute myeloid leukemia, or myelodysplastic syndrome: a center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant 23:436–444
Martinez-Borra J et al (2000) HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol 61:131–139
Yang H et al (2015) Histone deacetylase inhibitor SAHA epigenetically regulates miR-17–92 cluster and MCM7 to upregulate MICA expression in hepatoma. Br J Cancer 112:112
Yang J et al (2018) Decreased miR-17-92 cluster expression level in serum and granulocytes preceding onset of antithyroid drug-induced agranulocytosis. Endocrine 59:218–225
Pan J et al (2017) Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway. Oncotarget 8:65743
This work was supported by National Key R&D Program of China (2018YFC1314800); Shaanxi Provincial Natural Science Foundation of China (2017JQ8010; 2017SF-171); National Natural Science Foundation of China (No.31301949); the Fundamental Research Funds for the Central Universities (xjj2017135).
Conflict of interest
The authors declare no competing financial interests.
This study was approved by the Medical ethics committee of the First Ailiated Hospital of Xi’an Jiaotong University (ethical approval no. KYLLSL-2013-107-01). All experimental procedures were performed according to standard guidelines and procedures approved by the above Ethics Committee.
Informed consent was obtained from all participants.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Ma, P., Chen, P., Gao, J. et al. Association of MICA gene polymorphisms with thionamide-induced agranulocytosis. J Endocrinol Invest 44, 363–369 (2021). https://doi.org/10.1007/s40618-020-01319-0
- Thionamide-induced agranulocytosis
- Graves’ disease